This Day On The Street
Continue to site right-arrow
This account is pending registration confirmation. Please click on the link within the confirmation email previously sent you to complete registration.
Need a new registration confirmation email? Click here
Stocks Under $10 with 50-100% upside potential - 14 days FREE!

Global Hemoglobin A1c Monitoring Industry


Abbott Laboratories ( USA) II-44

Axis-Shield plc (UK) II-44

Bayer Healthcare Diabetes Care ( USA) II-45

Beckman Coulter, Inc. ( USA) II-45

Bio-Rad Laboratories Inc ( USA) II-45

Diabetes Technologies Inc ( USA) II-46

Geonostics, Inc. ( USA) II-46

HEMOCUE® AB ( Sweden) II-47

Menarini Diagnostics (UK) II-47

Roche Diagnostics ( Switzerland) II-47

Siemens Healthcare Diagnostics ( Germany) II-47

Tosoh Bioscience, Inc ( USA) II-48

Trinity Biotech plc ( Ireland) II-48


Table 7: World Recent Past, Current and Future Analysis for

HbA1c Monitoring by Geographic Region - US, Europe, and Rest

of World Markets Independently Analyzed with Annual Sales

Figures in US$ Million for Years 2010 through 2018 (includes

corresponding Graph/Chart) II-49

Table 8: World Historic Review for HbA1c Monitoring by

Geographic Region - US, Europe, and Rest of World Markets

Independently Analyzed with Annual Sales Figures in US$

Million for Years 2004 through 2009 (includes corresponding

Graph/Chart) II-50

Table 9: World 15-Year Perspective for HbA1c Monitoring by

Geographic Region - Percentage Breakdown of Dollar Sales for

US, Europe and Rest of World Markets for the Years 2004, 2011

& 2018 (includes corresponding Graph/Chart) II-51



A.Market Analysis III-1

An Insight III-1

Current and Future Analysis III-1

Market Dynamics and Trends III-1

HbA1c - Increasingly Moving into Physician's Office III-1

HbA1c Testing for Diabetes Detection Gains Support III-1

ADA Recommends HbA1c Test for Diabetes Diagnosis III-2

Rising Inclination towards CLIA-Waived Tests III-2

Need for Further Stringency in Requirements Arises III-2

5 of 8

Select the service that is right for you!

Action Alerts PLUS
Try it NOW

Jim Cramer and Stephanie Link actively manage a real portfolio and reveal their money management tactics while giving advanced notice before every trade.

Product Features:
  • $2.5+ million portfolio
  • Large-cap and dividend focus
  • Intraday trade alerts from Cramer
  • Weekly roundups
TheStreet Quant Ratings
Try it NOW
Only $49.95/yr

Access the tool that DOMINATES the Russell 2000 and the S&P 500.

Product Features:
  • Buy, hold, or sell recommendations for over 4,300 stocks
  • Unlimited research reports on your favorite stocks
  • A custom stock screener
  • Upgrade/downgrade alerts
Stocks Under $10
Try it NOW

David Peltier, uncovers low dollar stocks with extraordinary upside potential that are flying under Wall Street's radar.

Product Features:
  • Model portfolio
  • Stocks trading below $10
  • Intraday trade alerts
  • Weekly roundups
Dividend Stock Advisor
Try it NOW

Jim Cramer's protege, David Peltier, identifies the best of breed dividend stocks that will pay a reliable AND significant income stream.

Product Features:
  • Diversified model portfolio of dividend stocks
  • Alerts when market news affect the portfolio
  • Bi-weekly updates with exact steps to take - BUY, HOLD, SELL
Real Money Pro
Try it NOW

All of Real Money, plus 15 more of Wall Street's sharpest minds delivering actionable trading ideas, a comprehensive look at the market, and fundamental and technical analysis.

Product Features:
  • Real Money + Doug Kass Plus 15 more Wall Street Pros
  • Intraday commentary & news
  • Ultra-actionable trading ideas
Options Profits
Try it NOW

Our options trading pros provide daily market commentary and over 100 monthly option trading ideas and strategies to help you become a well-seasoned trader.

Product Features:
  • 100+ monthly options trading ideas
  • Actionable options commentary & news
  • Real-time trading community
  • Options TV
To begin commenting right away, you can log in below using your Disqus, Facebook, Twitter, OpenID or Yahoo login credentials. Alternatively, you can post a comment as a "guest" just by entering an email address. Your use of the commenting tool is subject to multiple terms of service/use and privacy policies - see here for more details.
Submit an article to us!


DOW 17,804.80 +26.65 0.15%
S&P 500 2,070.65 +9.42 0.46%
NASDAQ 4,765.38 +16.9840 0.36%

Brokerage Partners

Rates from

  • Mortgage
  • Credit Cards
  • Auto

Free Newsletters from TheStreet

My Subscriptions:

After the Bell

Before the Bell

Booyah! Newsletter

Midday Bell

TheStreet Top 10 Stories

Winners & Losers

Register for Newsletters
Top Rated Stocks Top Rated Funds Top Rated ETFs